1 year ago
115 About the speakers
Dr. Kizzmekia Corbett, Lead Scientist, COVID-19 mRNA Vaccine Development; Assistant Professor, Harvard T.H. Chan School of Public Health
Dr. Kizzmekia Corbett was the technological pb of the Vaccine Research Center’s coronavirus squad astatine the U.S. National Institutes of Health wherever she studied coronavirus biology and vaccine development. Those 6 years of probe led to the groundbreaking find that a stabilized mentation of a spike protein, which is recovered connected the aboveground of each coronaviruses, would beryllium a cardinal people for vaccines, treatments, and diagnostics. At the onset of the COVID-19 pandemic, she and her colleagues were cardinal to the improvement of the Moderna mRNA vaccine and the Eli Lilly therapeutic monoclonal antibody, some of which were archetypal to participate objective trials successful the world. As a result, her enactment is having a important interaction connected ending the worst respiratory-disease pandemic successful much than 100 years. Dr. Corbett is present an adjunct prof successful the Department of Immunology and Infectious Diseases astatine the Harvard T.H. Chan School of Public Health, arsenic good arsenic the Shutzer Assistant Professor astatine Harvard’s Radcliffe Institute of Advanced Study and an Associate Member of the Phillip T. and Susan M. Ragon Institute. Her enactment present extends beyond the accelerated improvement of COVID-19 vaccines to the outlook of this pandemic and aboriginal viral pandemics.
Perhaps conscionable arsenic important arsenic her technological accomplishments, Dr. Corbett has burst onto the nationalist signifier arsenic the look of a divers and rising procreation of talented scientists who volition alteration the world. She is simply a stellar subject communicator, explaining the vaccine and the microorganism successful highly accessible ways to media outlets, 2 U.S. presidents, and audiences astir the globe.
Laurent Duvernay-Tardif, Graduate successful Medicine; Super Bowl Champion
Called “the astir absorbing antheral successful the NFL”, Laurent Duvernay-Tardif is an eight-year NFL veteran, Super Bowl champion, and the lone progressive NFL subordinate with a aesculapian degree. Just months aft his Super Bowl triumph with the Kansas City Chiefs — and successful the midst of the COVID-19 pandemic — Duvernay-Tardif stepped distant from shot to articulation the aesculapian beforehand lines. From the unthinkable highs of winning the SuperBowl to the burnout of moving arsenic an orderly, Duvernay-Tardif shares his singular idiosyncratic story, speaking to resiliency, leadership, and more.
As plans for the 2020 NFL play ramped up, Duvernay-Tardif stepped distant from the crippled helium loved, becoming the archetypal subordinate of the 2020 NFL play to publically opt-out. For the archetypal clip successful his singular career, Duvernay-Tardif couldn’t reconcile his duplicate passions of shot and medicine, and with his team’s Super Bowl triumph lone months down him, helium recovered himself connected the beforehand lines of the pandemic, moving successful a semipermanent attraction installation successful Quebec. While moving connected the beforehand lines, Duvernay-Tardif enrolled successful Harvard’s T.H. Chan School of Public Health.
Juergen Eckhardt, SVP and Head, Leaps by Bayer
Juergen Eckhardt is SVP and Head of Leaps by Bayer, the interaction concern portion of Bayer. The ngo of Leaps is to put successful breakthrough technologies and disruptive concern models successful the areas of healthcare and agriculture. Juergen has been a task capitalist since 2002 and presently serves connected the committee of Joyn Bio, Dewpoint, Century, Khloris, Oerth Bio, Immunitas, eGenesis, and others. Previously, Juergen was a absorption advisor and Associate Partner with McKinsey & Co. and a subordinate of McKinsey’s Healthcare Leadership Team. He began his vocation arsenic a radiologist astatine the University Hospital of Basel, Switzerland. Juergen received his M.D. from the University of Basel and his MBA from INSEAD successful Fontainebleau, France.
Elizabeth Bramson-Boudreau, CEO and Publisher, MIT Technology Review
Elizabeth Bramson-Boudreau is the CEO and steadfast of MIT Technology Review, the Massachusetts Institute of Technology’s autarkic media company.
Since Elizabeth took the helm of MIT Technology Review successful mid-2017, the concern has undergone a monolithic translation from its erstwhile presumption arsenic a respected but niche people mag to a wide read, multi-platform media marque with a planetary assemblage and a sustainable business. Under her leadership, MIT Technology Review has been lauded for its editorial authority, its best-in-class events, and its caller usage of independent, archetypal probe to enactment some advertisers and readers.
Elizabeth has a 20-year inheritance successful gathering and moving teams astatine world-leading media companies. She maintains a keen absorption connected caller ways to commercialize media contented to entreaty to discerning, demanding consumers arsenic good arsenic B2B audiences.
Prior to joining MIT Technology Review, Elizabeth held a elder enforcement relation astatine The Economist Group, wherever her enactment stretched crossed concern lines and included mergers and acquisitions; editorial and merchandise instauration and modernization; sales; marketing; and events. Earlier successful her career, she worked arsenic a advisor advising exertion firms connected marketplace introduction and planetary expansion.
Elizabeth holds an enforcement MBA from the London Business School, an MSc from the London School of Economics, and a bachelor’s grade from Swarthmore College.
